OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-pharmacological management options for MAFLD: a practical guide
José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Renato Gama Ribeiro Leite Altikes, et al.
Therapeutic Advances in Endocrinology and Metabolism (2023) Vol. 14
Open Access | Times Cited: 21

Showing 21 citing articles:

Evidence summary of lifestyle interventions in adults with metabolic dysfunction-associated steatotic liver disease
Meijing Chen, Ying Chen, Jin-qing Lin, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access | Times Cited: 2

Thyme, oregano, and rosemary: herbs and food supplements for the management of metabolic associated fatty liver disease
Hamza Elbouny, Ayoub Amssayef, Rania Benjamaa, et al.
Nutrire (2025) Vol. 50, Iss. 1
Closed Access | Times Cited: 1

The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation
Ludovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 563-563
Open Access | Times Cited: 7

Advances in genetic variation in metabolism-related fatty liver disease
Fan Shi, Mei Zhao, Shudan Zheng, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 11

Investigation about the correlation between the severity of metabolic-associated fatty liver disease and adherence to the Mediterranean diet
Marjan Mokhtare, Arman Abdi, Amir M. Sadeghian, et al.
Clinical Nutrition ESPEN (2023) Vol. 58, pp. 221-227
Open Access | Times Cited: 11

The Role of Simple and Specialized Non-Invasive Tools in Predicting of Metabolic dysfunction-associated Fatty Liver Disease Severity and Prognosis
Marjan Mokhtare, Shahin Sharafeh, Mohammadjavad Sotoudeheian, et al.
Obesity Medicine (2025), pp. 100582-100582
Closed Access

Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis
Marina Takawy, Manal F. Abdelmalek
Current Diabetes Reports (2025) Vol. 25, Iss. 1
Closed Access

Luteolin Relieves Metabolic Dysfunction-Associated Fatty Liver Disease Caused by a High-Fat Diet in Rats Through Modulating the AdipoR1/AMPK/PPARγ Signaling Pathway
Pongsakorn Taweesap, Prapassorn Potue, Juthamas Khamseekaew, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3804-3804
Open Access

Hepatic Steatosis is Generated by the Gut Microbiota-Mitochondria Axis via 2-oleolyl Glycerol and Reverted by Functional Foods
Mónica Sánchez‐Tapia, Sandra Tobón‐Cornejo, Lilia G. Noriega, et al.
(2024)
Open Access | Times Cited: 3

Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment
Yuping Ding, Quanjun Deng, Mei Yang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 3303-3329
Open Access | Times Cited: 8

Hepatic Steatosis Can Be Partly Generated by the Gut Microbiota–Mitochondria Axis via 2-Oleoyl Glycerol and Reversed by a Combination of Soy Protein, Chia Oil, Curcumin and Nopal
Mónica Sánchez‐Tapia, Sandra Tobón‐Cornejo, Lilia G. Noriega, et al.
Nutrients (2024) Vol. 16, Iss. 16, pp. 2594-2594
Open Access | Times Cited: 1

Common Bean Suppresses Hepatic Ceramide Metabolism in a Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease
Vanessa K. Fitzgerald, Tymofiy Lutsiv, John N. McGinley, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3196-3196
Open Access | Times Cited: 1

Glucagon and glucagon‐like peptide‐1 dual agonist therapy: A possible future towards fatty kidney disease
Mehmet Kanbay, Mazlum Çöpür, Mustafa Güldan, et al.
European Journal of Clinical Investigation (2024)
Open Access | Times Cited: 1

Revolutionary Breakthroughs
Nahúm Méndez‐Sánchez, Mariana M. Ramírez-Mejía
(2024), pp. 115-124
Closed Access

A Patient-Centered Management of Patients with Diabetes Type 2: Are all Diabetic Patients the Same?
Zvonimir Bosnić, Dunja Šojat, Tomislav Kurevija, et al.
IntechOpen eBooks (2023)
Open Access

Page 1

Scroll to top